[Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients]
[Article in
Italian]
- PMID: 618241
Item in Clipboard
[Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients]
[Article in
Italian]
Boll Soc Ital Cardiol.
1977.
No abstract available
Similar articles
-
[Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent].Minerva Cardioangiol. 1979 Mar;27(3):113-8. Minerva Cardioangiol. 1979. PMID: 37462 Clinical Trial. Italian. No abstract available.
-
Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.Int J Clin Pharmacol Biopharm. 1979 Oct;17(10):380-5. Int J Clin Pharmacol Biopharm. 1979. PMID: 40887 Clinical Trial. No abstract available.
-
[Activity of a new derivative of 3-hydrazinopyridazine: ISF 2123 in patients with hypertension. I].Minerva Cardioangiol. 1975 Nov;23(11):735-47. Minerva Cardioangiol. 1975. PMID: 1223677 Italian. No abstract available.
-
Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient.J Card Surg. 2006 Mar-Apr;21 Suppl 1:S8-S14. doi: 10.1111/j.1540-8191.2006.00214.x. J Card Surg. 2006. PMID: 16492294 Review.
-
Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.Ann Pharmacother. 2009 Jul;43(7):1258-65. doi: 10.1345/aph.1L610. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584385 Review.